UK’s PinPoint Data Science to showcase AI cancer blood test at WHX Dubai 2026

UK—PinPoint Data Science has announced that its groundbreaking AI-enabled multi-cancer blood test, developed in partnership with the NHS in England, will feature prominently on the UK Pavilion at WHX Dubai 2026.

This announcement positions UK HealthTech innovation at the forefront of one of the world’s most influential healthcare platforms.

The company will showcase its technology on the ABHI UK Pavilion alongside a robust delegation of UK life sciences and health technology companies.

These organizations represent cutting-edge advances across multiple sectors, including diagnostics, medical technology, artificial intelligence, and digital health solutions.

Addressing Global Healthcare Challenges Through Machine Learning

The PinPoint Test addresses critical healthcare needs by supporting earlier cancer diagnosis while helping to alleviate pressure on overburdened healthcare systems worldwide.

The innovative test leverages machine learning technology and routinely collected blood biomarkers to generate clinically meaningful cancer risk assessments.

Following a comprehensive five-year real-world evaluation, the test functions as a diagnostic aid that enables clinicians to prioritize patients more effectively while simultaneously reducing unnecessary downstream testing procedures.

Dr. Nigel Sansom, Executive Chair at PinPoint Data Science, expressed enthusiasm about the company’s participation in WHX Dubai this year.

He emphasized that the event provides a rare opportunity for innovators like PinPoint to engage directly with decision-makers and frontline healthcare professionals from diverse international markets.

Dr. Sansom highlighted the revolutionary nature of their offering, describing it as machine learning applied as an upgrade to conventional blood testing.

He characterized the technology as a cost-effective tool designed to manage cancer risk more effectively without causing healthcare budgets to spiral out of control.

The product demonstrates adaptability by growing and evolving alongside changing healthcare service needs.

Building International Partnerships for Healthcare Solutions

Dr. Sansom identified these capabilities as essential responses to twenty-first-century healthcare challenges.

He expressed PinPoint’s commitment to collaborating with partners across all regions to deliver customized solutions that address specific local healthcare needs.

WHX Dubai, now hosted at the Dubai Exhibition Centre within Expo City Dubai, has transformed into a premier global health innovation summit.

The event attracts more than 4,000 visitors representing 180 countries, establishing itself as a major platform for international collaboration throughout the healthcare sector.

UK Life Sciences Excellence on Display

The ABHI UK Pavilion will demonstrate the extensive breadth of UK life sciences expertise spanning medical devices, diagnostics, digital health, AI-driven solutions, genomics, and pharmaceutical services.

The pavilion serves as a catalyst for companies seeking to forge partnerships that generate real-world impact and meaningful healthcare improvements.

As the exclusive UK representative for Informa Markets’ healthcare portfolio, ABHI leads one of the largest national pavilions at the exhibition.

The organization receives support from Invest Northern Ireland, the Welsh Government, and the Department for Business and Trade.

Michelle Michelucci, Head of International Events at ABHI, conveyed excitement about returning to Dubai for WHX 2026 with a strong delegation of UK innovators.

She noted the event’s significant growth in both scale and influence, expressing appreciation for its reimagined venue at Expo City.

Michelucci emphasized that the UK Pavilion will showcase British expertise ranging from early-stage startups to established global life sciences leaders.

The ABHI UK Pavilion maintains its position as a premier destination for exhibition visitors, offering strategic advantages including a central location, strong national branding, and comprehensive exhibitor support.

This support encompasses in-market guidance, curated networking opportunities, and direct introductions to senior healthcare buyers and decision-makers.